News
Arrowhead Pharmaceuticals, Inc.'s deal with Sarepta expands its pipeline, but limited plozasiran market and competition ...
If you are looking to squeeze more out of your investment portfolio, you might want to consider spicing things up with ...
Jefferies analyst Julien Dumoulin-Smith downgraded GE Vernova stock to Hold from Buy. His price target, however, rose to $517 ...
Wondering where CrowdStrike stock may be in five years? Learn what the current state of CRWD stock is and what its five year ...
We recently published a list of 12 AI Stocks on Latest News and Ratings. In this article, we are going to take a look at ...
Broadcom remains a strong Buy with a $265 target, backed by hyperscaler investments and XPU partnerships. Click here to find ...
Explore more
Bernstein analysts reiterated a positive stance on NVIDIA Corporation (NASDAQ:NVDA) even as the company faces regulatory ...
As Meta Platforms shifts focus and rides a bullish trend, investors should formulate a strategy for all likely outcomes. 24/7 ...
Microsoft (NASDAQ: MSFT) continues to provide investors with earnings beats and strong growth in its cloud, AI and gaming ...
Best Buy (BBY) stock is lower today, after reporting a first-quarter revenue miss and issues a dismal full-year sales outlook ...
Tesla Inc.'s investors are in a good mood Thursday, as they look for a now full-time Elon Musk as chief executive to clear the path for the electric-vehicle giant's stock to target a return to record ...
9h
MarketBeat on MSNTarget's Big Bet: Is It a Cheap Stock or a Value Trap?CompanyOverview|NYSE:TGT] Target Corporation (NYSE: TGT) investors find themselves stuck at a crossroads. The retailer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results